Health care startups that raised Series B in Guangdong, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Medefa | Zhuhai | Series B | $14.9M | 2026-09-02 |
| MileBot Robotics | Shenzhen | Series B | $14.9M | 2026-08-26 |
| Hongxin Biology | Shenzhen | Series B | $14.0M | 2026-08-13 |
| Sonosemi Medical | Shenzhen | Series B | $27.3M | 2026-07-08 |
| Menovex | Shenzhen | Series B | $14.8M | 2026-06-02 |
| Hypershell | Shenzhen | Series B | $50.0M | 2026-05-18 |
| Salus BioMed | Shenzhen | Series B | $7.0M | 2025-10-09 |
| MacroLux | Shenzhen | Series B | $14.0M | 2024-10-23 |
8 rows of the CSV in 5 of its 18 columns.
- The 103 health care startups in Guangdong, China whose last round is Series B have raised $2.3B in total.
- 23 of them closed their most recent round in the last 12 months, $218.7M combined.
- The largest of those rounds is Hypershell's $50.0M Series B, dated May 2026.
- The most recent is Deepin Medical's $14.9M Series B on 19 October 2026.
- Legend Capital is an investor in 3 of them, more than any other fund.
- Biotech is the most common other sector, with 35 companies (34%).
- 16% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 51 to 100 employees (31% of companies with a recorded size).
- 1 is a unicorn, valued at $1 billion or more.
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
9 of 103| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Medefa | Medefa uses synthetic biology to mass-produce novel PHA biomaterials. | Biotech | Zhuhai | Series B | $14.9M | 2026-09-02 | $16.3M | Motianshi Touzi, Taiping Innovation | 11 to 50 | 2019 |
| MileBot Robotics | MileBot Robotics develops robots for medical and healthcare applications. | Artificial intelligence | Shenzhen | Series B | $14.9M | 2026-08-26 | $14.9M | Lenovo Capital and Incubator Group (LCIG), Share Capital, Shangyuan Capital | 101 to 250 | 2016 |
| Hongxin Biology | Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. | Biotech | Shenzhen | Series B | $14.0M | 2026-08-13 | $14.0M | Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | 11 to 50 | 2021 |
| Sonosemi Medical | Sonosemi Medical provides medical devices for vascular interventional diagnosis and treatment. | Health care | Shenzhen | Series B | $27.3M | 2026-07-08 | $27.3M | Eight Roads Ventures, Co-Stone Venture Capital, Guangzhou Yuexiu Industrial Investment Fund +1 | 101 to 250 | 2020 |
| Menovex | Menovex develops and markets laser medical devices for treating oral and skin conditions. | Health care | Shenzhen | Series B | $14.8M | 2026-06-02 | $14.8M | Infinity Equity | 2019 | |
| Hypershell | Hypershell develops wearable exoskeletons that support walking, hiking, and cycling. | Artificial intelligence | Shenzhen | Series B | $50.0M | 2026-05-18 | $121.2M | MiraclePlus, Decent Capital, Vitalbridge Capital | 101 to 250 | 2021 |
| PVmed | PVmed focuses on AI-enhanced auxiliary diagnosis and treatment. | Artificial intelligence | Guangzhou | Series B | $12.7M | 2024-02-01 | $26.7M | China Growth Capital, Shenzhen Guozhong Venture Capital Management, COCOCapital +1 | 51 to 100 | 2017 |
| Fermion Technology | Fermion applies AI and deep learning to speed medicine development and expand treatment options. | Artificial intelligence | Guangzhou | Series B | $14.8M | 2022-07-18 | Welight Capital, Zhengxuan Investment, Challenjers Capital +1 | 51 to 100 | 2015 | |
| DMAI | DMAI builds cognitive AI platforms. | Artificial intelligence | Guangzhou | Series B | $74.6M | 2022-07-04 | IDG Capital, Lenovo Capital and Incubator Group (LCIG), CDH Investments +1 | 101 to 250 | 2017 |
Table 1. Health care startups that raised Series B in Guangdong, China: the 9 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 103.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hypershell | Hypershell develops wearable exoskeletons that support walking, hiking, and cycling. | Artificial intelligence | Shenzhen | Series B | $50.0M | 2026-05-18 | $121.2M | MiraclePlus, Decent Capital, Vitalbridge Capital | 101 to 250 | 2021 |
| 2 | Sonosemi Medical | Sonosemi Medical provides medical devices for vascular interventional diagnosis and treatment. | Health care | Shenzhen | Series B | $27.3M | 2026-07-08 | $27.3M | Eight Roads Ventures, Co-Stone Venture Capital, Guangzhou Yuexiu Industrial Investment Fund +1 | 101 to 250 | 2020 |
| 3 | MileBot Robotics | MileBot Robotics develops robots for medical and healthcare applications. | Artificial intelligence | Shenzhen | Series B | $14.9M | 2026-08-26 | $14.9M | Lenovo Capital and Incubator Group (LCIG), Share Capital, Shangyuan Capital | 101 to 250 | 2016 |
| 4 | Medefa | Medefa uses synthetic biology to mass-produce novel PHA biomaterials. | Biotech | Zhuhai | Series B | $14.9M | 2026-09-02 | $16.3M | Motianshi Touzi, Taiping Innovation | 11 to 50 | 2019 |
| 5 | Menovex | Menovex develops and markets laser medical devices for treating oral and skin conditions. | Health care | Shenzhen | Series B | $14.8M | 2026-06-02 | $14.8M | Infinity Equity | 2019 | |
| 6 | Hongxin Biology | Hongxin Biology develops mRNA drugs and delivers nucleic acid therapeutics to patients. | Biotech | Shenzhen | Series B | $14.0M | 2026-08-13 | $14.0M | Haiyuan Capital, Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | 11 to 50 | 2021 |
Table 2. Health care startups that raised Series B in Guangdong, China: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Legend Capital | Venture capital firm | Beijing, China | 3 | 3% | ||
| 2 | Lenovo Capital and Incubator Group (LCIG) | Venture capital firm | Beijing, China | 2 | 2% | 1 | MileBot Robotics |
| 3 | Eight Roads Ventures | Venture capital firm | London, United Kingdom | 2 | 2% | 1 | Sonosemi Medical |
| 4 | Guangzhou Yuexiu Industrial Investment Fund | Corporate venture arm | Guangzhou, China | 2 | 2% | 1 | Sonosemi Medical |
| 5 | IDG Capital | Private equity firm | Beijing, China | 2 | 2% | ||
| 6 | Taiping Innovation | Private equity firm | 1 | 1% | 1 | Medefa | |
| 7 | Motianshi Touzi | Guangzhou, China | 1 | 1% | 1 | Medefa | |
| 8 | Shangyuan Capital | Private equity firm | Shenzhen, China | 1 | 1% | 1 | MileBot Robotics |
| 9 | Share Capital | Venture capital firm | Shenzhen, China | 1 | 1% | 1 | MileBot Robotics |
| 10 | Haiyuan Capital | Venture capital firm | Shenzhen, China | 1 | 1% | 1 | Hongxin Biology |
| 11 | Shenzhen Small & Medium Enterprises Credit Financing Guarantee Group | Micro VC fund | Shenzhen, China | 1 | 1% | 1 | Hongxin Biology |
| 12 | CCB Equity | Private equity firm | Beijing, China | 1 | 1% | 1 | Sonosemi Medical |
| 13 | Co-Stone Venture Capital | Private equity firm | Shenzhen, China | 1 | 1% | 1 | Sonosemi Medical |
| 14 | Infinity Equity | Private equity firm | Wan Chai, Hong Kong | 1 | 1% | 1 | Menovex |
| 15 | TaiKun Fund | Venture capital firm | 1 | 1% | 1 | ROBO Medical |
Table 3. Health care startups that raised Series B in Guangdong, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups that raised Series B in Guangdong, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series B | 103 | 100% | $14.1M |
Table 5. Health care startups that raised Series B in Guangdong, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Health care startups that raised Series B in Guangdong, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 13% | $25.4M |
| September 2026 | 2 | 9% | $14.9M |
| August 2026 | 3 | 13% | $43.4M |
| July 2026 | 1 | 4% | $27.3M |
| June 2026 | 3 | 13% | $14.8M |
| May 2026 | 2 | 9% | $50.0M |
| April 2026 | 2 | 9% | $14.6M |
| March 2026 | 3 | 13% | $28.3M |
| February 2026 | 1 | 4% | |
| January 2026 | 2 | 9% | |
| December 2025 | 1 | 4% |
Table 7. Health care startups that raised Series B in Guangdong, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 22 | 21% | $218.7M |
| 2025 | 7 | 7% | $117.3M |
| 2024 | 8 | 8% | $132.2M |
| 2023 | 12 | 12% | $101.6M |
| 2022 | 13 | 13% | $257.4M |
| 2021 | 4 | 4% | $115.5M |
Table 8. Health care startups that raised Series B in Guangdong, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 1% |
| 2020 to 2022 | 15 | 15% |
| 2015 to 2019 | 42 | 42% |
| 2010 to 2014 | 23 | 23% |
| Before 2010 | 20 | 20% |
Table 9. Health care startups that raised Series B in Guangdong, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 8 | 9% |
| 11 to 50 | 21 | 23% |
| 51 to 100 | 28 | 31% |
| 101 to 250 | 20 | 22% |
| 251 to 500 | 10 | 11% |
| 501 to 1,000 | 2 | 2% |
| 1,001 to 5,000 | 2 | 2% |
Table 10. Health care startups that raised Series B in Guangdong, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series B and its headquarters is in Guangdong, China. On 16 November 2026 that is 103 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 9 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 103 rows: 37 have no round amount, 0 no city and 36 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Guangdong, China whose last round is Series B are on the list?
- 103, in the file dated 16 November 2026. 23 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 103 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.